Skip to main content

Table 1 Demographic and clinical characteristics of patients on ART, and facility-related indicators in Andhra Pradesh and Telangana (2007-12) and in Rajasthan (2008-13)

From: Survival outcomes for first-line antiretroviral therapy in India’s ART program

  Andhra Pradesh and Telangana (N = 3,340)a Rajasthan (N = 3,241)b
Variables Total (% of N) Deceased (%) Total (% of N) Deceased (%)
Patient level
Year of ART initiationc
  2007-08 365 (10.9) 58 (15.9)   
  2008-09 458 (13.7) 68 (14.9) 422 (13.0) 72 (17.1)
  2009-10 767 (23.0) 97 (12.7) 651 (20.1) 67 (10.3)
  2010-11 829 (24.8) 124 (15.0) 749 (23.1) 90 (12.0)
  2011-12 919 (27.5) 90 (9.8) 850 (26.2) 85 (10.0)
  2012-13    569 (17.6) 79 (13.9)
Sex of patient
  Male 1,724 (51.6) 273 (15.8) 1,860 (57.4) 285 (15.3)
  Female 1,561 (46.7) 159 (10.2) 1,360 (42.0) 108 (7.9)
Age of patients (years)
  16–29 857 (25.7) 98 (11.4) 720 (22.2) 66 (9.2)
  30–49 2,152 (64.4) 287 (13.3) 2,250 (69.4) 278 (12.4)
  = >50 329 (9.9) 52 (15.8) 271 (8.4) 49 (18.1)
CD4 count at ART initiation (cells/mm3)
  < =100 782 (23.4) 168 (21.5) 954 (29.4) 209 (21.9)
  101–250 1,870 (56.0) 226 (12.1) 1,562 (48.2) 150 (9.6)
  >250 659 (19.7) 41 (6.2) 696 (21.5) 31 (4.5)
Co-existing tuberculosis
  No 2,823 (84.5) 336 (11.9) 2,582 (79.7) 276 (10.7)
  Yes 515 (15.4) 101 (19.6) 627 (19.4) 117 (18.7)
Ever use of alcohol
  No 2,739 (82.0) 319 (11.7) 2,709 (83.6) 299 (11.0)
  Yes 599 (17.9) 118 (19.7) 519 (16.0) 94 (18.1)
Baseline ART regimend
  STV based regimen with/without EFV 1,377 (41.2) 215 (15.6) 832 (25.7) 146 (17.6)
  ZDV based regimen with/without EFV 1,542 (46.2) 166 (10.8) 2,131 (65.8) 205 (9.6)
Facility level variables
Cumulative ART patient loade
  Below or equal to state average 1,891 (56.6) 262 (13.9) 1,621 (50.0) 190 (11.7)
  Above state average 1,449 (43.4) 175 (12.1) 1,620 (50.0) 203 (12.5)
Ratio of cumulative ART patients to pre-ART patientsf
  Below or equal to state average 1,998 (59.8) 275 (13.8) 2,433 (75.1) 271 (11.1)
  Above state average 1,342 (40.2) 162 (12.1) 808 (24.9) 122 (15.1)
Percent of cumulative loss to follow-up patients g
  Category 1 1,070 (32.0) 123 (11.5) 1,352 (41.7) 174 (12.9)
  Category 2 1,090 (32.6) 148 (13.4) 1,375 (42.4) 150 (10.9)
  Category 3 1,180 (35.3) 166 (14.1) 514 (15.9) 69 (13.4)
  1. aData missing for Andhra Pradesh and Telangana: year of ART initiation for 2; sex of patients for 55; age of patients for 2; CD4 count at ART initiation for 29; co-existing tuberculosis for 2; ever use of alcohol for 2; baseline ART regimen for 421
  2. bData missing for Rajasthan: sex of patients for 21; CD4 count at ART initiation for 29; co-existing tuberculosis for 32; ever use of alcohol for 13; baseline ART regimen for 278
  3. cFinancial year
  4. dSTV is Stavudine, ZDV is Zidovudine, and EFV is Efavirenz
  5. eAverage for Andhra Pradesh and Telangana is 4844 and 4307 for Rajasthan
  6. fFor Andhra Pradesh and Telangana is 0.59 and 0.70 for Rajasthan
  7. gThe categories for Andhra Pradesh and Telangana are <5.6 %, >5.6–8.4 % and >8.4 %; and <3.1 %, 3.1–6.5 % and >6.5 % for Rajasthan